Brr Op Co, LLC Provectus Biopharmaceuticals, Inc. Transaction History

Brr Op Co, LLC

  • $815 Million
  • Q3 2022

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

Apr 26, 2019
SELL
$0.05 - $0.07 $2,000 - $2,800
-40,000 Closed
0 $0
Q4 2017

Feb 13, 2018
BUY
$0.03 - $0.08 $1,200 - $3,200
40,000
40,000 $3,000

Others Institutions Holding PVCT

# of Institutions
7
Shares Held
229K
Call Options Held
0
Put Options Held
0
View Full List

About PROVECTUS BIOPHARMACEUTICALS, INC.

PVCT Quotes by TradingView
  • Ticker PVCT
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 419,496,992
  • Market Cap $41.9M
  • Description
  • Provectus Biopharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing immunotherapy medicines based on halogenated xanthenes. It develops PV-10, an investigational autolytic cancer immunotherapy for adult solid tumor cancers, such as melanoma and gastrointestinal tumors, including hepatocellular carcinoma; colorectal ...
More about PVCT
Track This Portfolio

Track Brr Op Co, LLC Portfolio

Follow Brr Op Co, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brr Op Co, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brr Op Co, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email